trial

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

NCTId NCT07098169
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 201 (estimated)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2028-02-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
201 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2025-09-01
Primary completion
2028-02-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
iTEST

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
The University of Texas at DallasCollaborator
University of MiamiCollaborator

Investigators

1
Amy Pinkham, PhDPrincipal Investigator

Sites

3 total
San Diego, United StatesMiami, United StatesDallas, United States

Facts & assertions

4 sourced
Enrollment
201
Phase
NA
Primary Completion Date
2028-02-01
Status
RECRUITING
relationships
The graph out of here
drug
iTEST
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
collaborator
National Institute of Mental Health (NIMH)
company
The University of Texas at Dallas
company
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
Schizophrenia Disorders
indication
investigator
Amy Pinkham, PhD
person